-
Oberoi Realty
1,751.00 1,440.05(%) -
Canara Bank
106.35 78.58(%) -
SpiceJet
40.84 79.90(%) -
Lodha Developers
1,330.55 1,036.00(%) -
Havells India
1,549.05 1,360.05(%) -
ICICI Bank
1,489.95 1,482.00(%) -
One 97
1,090.00 1,063.00(%) -
Bombay Dyeing
190.85 256.25(%) -
Ola Electric
43.95 157.53(%) -
Dixon Technolog.
16,671.15 19,149.80(%) -
Anthem Bioscienc
765.00 752.50(%) -
Eternal Ltd
303.60 311.60(%) -
Paradeep Phosph.
205.60 193.15(%) -
Pidilite Inds.
2,900.75 2,620.15(%) -
Reliance Industr
1,426.90 1,551.00(%) -
I R F C
136.90 209.10(%) -
St Bk of India
825.00 895.30(%) -
Waaree Energies
3,199.00 3,740.75(%) -
Jayaswal Neco
43.10 55.34(%) -
Tata Motors
692.95 1,179.05(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Dr Reddys Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Dr. Reddy's
- BSE Code : 815.0
- ISIN : INE089A01031
-
Today’s Low
1,236.00 -
Today’s High
1,263.60

-
Open
1,261.00 -
Perv Close
1,259.30 -
52W Low
1,020.00 -
52W High
1,421.49
Key Indicators
-
P/E(TTM)
19.24
-
Mar.Cap (₹Cr.)
103,488.14
-
Div & Yield %
0.64
-
Book Value(₹)
345.76
-
Debt-Equity Ratio
-1.53
-
AGM Date
22-Jul-2025
-
EPS
64.48
-
P/E Ratio
19.24
Financials Ratios
-
Debt-Equity Ratio
0.06
-
Mar.Cap (₹Cr.)
103,488.14
-
RONW (%)
21.64
-
ROCE (%)
26.59
Score Board
-
Equity (₹ in Cr.)
83.46
-
BV (₹)
345.80
-
Sales( ₹ in Cr.)
23,115.40
-
NP (in Cr.)
5,381.04
-
NP Var(%)
26.0
-
Div%
800.0
-
CPS (₹)
76.90
-
EPS (₹)
64.50
-
Traded Value (₹ in Lakhs)
103,521.52
-
52 Week High
1,421.49
-
52 Week Low
1,020.00
-
Price BSE
1240.0
-
Price NSE
1,240.00
-
Market Capital( in Cr.)
103,521.52
-
P/C Ratio
16.10
-
P/E Ratio
19.20
-
Price Vs.BV
64.50
-
22-Jul-2025( 09:53)
Hot Pursuit - Dr Re... - In a regulatory filing, the co...
-
02-Jul-2025( 01:35)
Hot Pursuit - Dr Re... - <p>Dr Reddys Laboratories Ltd...
-
24-Jun-2025( 09:53)
Corporate News - Dr Re... - Dr Reddys Laboratories will ho...
-
23-Jun-2025( 06:31)
Corporate News - Dr Re... - Dr Reddys Laboratories has all...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 23,115.40 | 19,483.80 | 16,962.50 | 14,405.20 | 13,349.10 | 11,850.40 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 23,115.40 | 19,483.80 | 16,962.50 | 14,405.20 | 13,349.10 | 11,850.40 |
Other Income | 1,003.40 | 862.30 | 591.30 | 482.00 | 801.10 | 743.20 |
Stock Adjustments | 173.90 | 238.80 | -129.50 | 389.60 | 395.60 | 99.90 |
Total Income | 24,292.70 | 20,584.90 | 17,424.30 | 15,276.80 | 14,545.80 | 12,693.50 |
EXPENDITURE : | ||||||
Raw Materials | 6,239.60 | 5,278.10 | 4,940.70 | 5,435.50 | 4,518.60 | 3,673.70 |
Power and Fuel Cost | 480.10 | 454.40 | 398.10 | 326.80 | 291.30 | 290.50 |
Employee Cost | 3,287.50 | 3,085.70 | 2,832.60 | 2,434.60 | 2,270.10 | 2,030.20 |
Other Manufacturing Expenses | 1,949.80 | 1,556.00 | 1,257.90 | 1,038.90 | 953.00 | 814.40 |
Selling and Administration Expenses | 3,500.00 | 3,064.60 | 2,782.80 | 2,672.90 | 2,274.90 | 2,026.80 |
Miscellaneous Expenses | 450.50 | 357.40 | 406.10 | 292.00 | 300.00 | 245.10 |
Employee Benefit Expenses | 3,287.50 | 3,085.70 | 2,832.60 | 2,434.60 | 2,270.10 | 2,030.20 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 15,907.50 | 13,796.20 | 12,618.20 | 12,200.70 | 10,607.90 | 9,080.70 |
Operating Profit | 8,385.20 | 6,788.70 | 4,806.10 | 3,076.10 | 3,937.90 | 3,612.80 |
Interest | 109.90 | 21.80 | 16.90 | 38.00 | 46.70 | 47.80 |
Gross Profit | 8,275.30 | 6,766.90 | 4,789.20 | 3,038.10 | 3,891.20 | 3,565.00 |
Depreciation | 1,039.40 | 975.60 | 923.20 | 814.30 | 835.00 | 789.20 |
Profit Before Tax | 7,235.90 | 5,791.30 | 3,866.00 | 2,223.80 | 3,056.20 | 2,775.80 |
Current Tax | 1,790.50 | 1,361.80 | 864.10 | 392.60 | 540.10 | 483.90 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 96.00 | 87.50 | 389.10 | 208.00 | 329.70 | -645.80 |
Reported Net Profit | 5,349.40 | 4,342.00 | 2,612.80 | 1,623.20 | 2,186.40 | 2,937.70 |
Extraordinary Items | -31.64 | 57.81 | -15.75 | -5.69 | 337.02 | -11.15 |
Adjusted Net Profit | 5,381.04 | 4,284.19 | 2,628.55 | 1,628.89 | 1,849.38 | 2,948.85 |
Adjustment below Net Profit | 0.00 | 0.10 | 0.00 | 0.00 | 0.30 | 0.00 |
P & L Balance brought forward | 21,205.40 | 17,504.80 | 15,403.00 | 14,137.30 | 12,497.90 | 9,951.10 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 600.90 | 641.50 | 511.00 | 357.50 | 547.30 | 390.90 |
P & L Balance carried down | 25,953.90 | 21,205.40 | 17,504.80 | 15,403.00 | 14,137.30 | 12,497.90 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 800.00 | 800.00 | 800.00 | 600.00 | 500.00 | 500.00 |
Dividend Per Share(Rs) | 8.00 | 40.00 | 40.00 | 30.00 | 25.00 | 25.00 |
Earnings Per Share-Unit Curr | 64.14 | 260.31 | 156.83 | 97.55 | 131.39 | 176.76 |
Earnings Per Share(Adj)-Unit Curr | 64.14 | 52.06 | 31.37 | 19.51 | 26.28 | 35.35 |
Book Value | 346.00 | 1,453.29 | 1,236.56 | 1,111.56 | 1,032.48 | 920.13 |
Book Value(Adj)-Unit Curr | 346.00 | 290.66 | 247.31 | 222.31 | 206.50 | 184.03 |